PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-10-05

Date Title Company
05-Oct-2023 Celltrion USA has signed a contract with Ventegra® to add Yuflyma® (adalimumab-aaty) as a preferred formulary product in both public and private insurance markets Businesswire
05-Oct-2023 Joseph Jimenez, Global Quality Leader, Joins Validant Group Businesswire
05-Oct-2023 Thermo Fisher Scientific Expands St. Louis Manufacturing for Complex Biologic Treatments Businesswire
05-Oct-2023 Stevanato Group Announces Voting Results from its Extraordinary General Meeting Businesswire
05-Oct-2023 Elligo Health Research Announces Expansion of Study Marketplace With Syneos Health Businesswire
05-Oct-2023 EngFlow and tipi.build Reveal CMake Remote Build Execution Solution for C and C++ Community Businesswire
05-Oct-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Medical Properties Trust, Inc. (MPW) on Behalf of Investors Businesswire
05-Oct-2023 Global Plasma Fractionation Market Valued at $5 Billion in 2023, Expected to Surge with 10% CAGR by 2035 - ResearchAndMarkets.com Businesswire
05-Oct-2023 Global Enzyme Replacement Therapy (ERT) Market Research Report 2023-2032 Featuring Key Players - Biomarin Pharmaceutical, Leadiant Biosciences, Pfizer, Sanofi, & AbbVie - ResearchAndMarkets.com Businesswire
05-Oct-2023 Oral Drug Delivery Market Size, Share, Trends, Demand, Growth Forecast, Segmentation and Revenue Outlook The Wire Times
05-Oct-2023 Global Myeloproliferative Disorders Drugs Research Report 2023: Market is Expected to Surpass $10.5 Bn in 2027 - Focus on JAK2 Inhibitors, Anti-Neoplastics, Demethylation Agents, Imatinib Mesylate - ResearchAndMarkets.com Businesswire
05-Oct-2023 The Hackett Group Announces 2023 Digital Award Winners Businesswire
05-Oct-2023 GE HealthCare and University Hospitals Enter 10-Year Strategic Collaboration to Contemporize Its Imaging Fleet and Implement Enterprise Digital Solutions to Help Improve Patient Care and Optimize Processes Businesswire
05-Oct-2023 Global Sustained Release Excipients Research Report 2023: Embracing the Future of Drug Delivery - The Growing Demand for Sustained-Release Excipients to 2032 - ResearchAndMarkets.com Businesswire
05-Oct-2023 Emalex Biosciences Releases Results of 12-Month Open-Label Extension Study for Tourette Syndrome Candidate Businesswire
05-Oct-2023 Drug Addiction Treatement Market it would Grow up to USD 30,789.21 Million by 2030 The Wire Times
05-Oct-2023 Section 32 Closes $525 Million Oversubscribed Fund 5 to Accelerate the Discovery, Development, and Distribution of Revolutionary Technologies Businesswire
05-Oct-2023 Hoth Therapeutics Announces Merveille.ai Artificial intelligence Initiative for Drug Discovery Hoth Therapeutics
05-Oct-2023 Impel Pharmaceuticals Announces Exploration of Strategic Alternatives Impel Pharmaceuticals
05-Oct-2023 Sharp acquires Berkshire Sterile Manufacturing Sharp